260 related articles for article (PubMed ID: 14522846)
1. Biochemistry and structure of PrP(C) and PrP(Sc).
Riesner D
Br Med Bull; 2003; 66():21-33. PubMed ID: 14522846
[TBL] [Abstract][Full Text] [Related]
2. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
3. Sonication induced intermediate in prion protein conversion.
Zukas AA; Bruederle CE; Carter JM
Protein Pept Lett; 2008; 15(2):206-11. PubMed ID: 18289112
[TBL] [Abstract][Full Text] [Related]
4. Immunoaffinity purification and neutralization of scrapie prions.
Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
[TBL] [Abstract][Full Text] [Related]
5. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human prion protein inhibits prion propagation in vitro.
Yuan J; Zhan YA; Abskharon R; Xiao X; Martinez MC; Zhou X; Kneale G; Mikol J; Lehmann S; Surewicz WK; Castilla J; Steyaert J; Zhang S; Kong Q; Petersen RB; Wohlkonig A; Zou WQ
Sci Rep; 2013 Oct; 3():2911. PubMed ID: 24105336
[TBL] [Abstract][Full Text] [Related]
7. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
Prion; 2014; 8(4):314-8. PubMed ID: 25482603
[TBL] [Abstract][Full Text] [Related]
8. Dynamic analyses of PrP and PrP(Sc) in brain tissues of golden hamsters infected with scrapie strain 263K revealed various PrP forms.
Gao JM; Gao C; Han J; Zhou XB; Xiao XL; Zhang J; Chen L; Zhang BY; Hong T; Dong XP
Biomed Environ Sci; 2004 Mar; 17(1):8-20. PubMed ID: 15202859
[TBL] [Abstract][Full Text] [Related]
9. Infrared microspectroscopy detects protein misfolding cyclic amplification (PMCA)-induced conformational alterations in hamster scrapie progeny seeds.
Daus ML; Wagenführ K; Thomzig A; Boerner S; Hermann P; Hermelink A; Beekes M; Lasch P
J Biol Chem; 2013 Dec; 288(49):35068-80. PubMed ID: 24163371
[TBL] [Abstract][Full Text] [Related]
10. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein.
Stöhr J; Elfrink K; Weinmann N; Wille H; Willbold D; Birkmann E; Riesner D
Biol Chem; 2011 May; 392(5):415-21. PubMed ID: 21476870
[TBL] [Abstract][Full Text] [Related]
11. Conversion efficiency of bank vole prion protein in vitro is determined by residues 155 and 170, but does not correlate with the high susceptibility of bank voles to sheep scrapie in vivo.
Piening N; Nonno R; Di Bari M; Walter S; Windl O; Agrimi U; Kretzschmar HA; Bertsch U
J Biol Chem; 2006 Apr; 281(14):9373-84. PubMed ID: 16455657
[TBL] [Abstract][Full Text] [Related]
12. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
13. Structural studies of the scrapie prion protein by electron crystallography.
Wille H; Michelitsch MD; Guenebaut V; Supattapone S; Serban A; Cohen FE; Agard DA; Prusiner SB
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3563-8. PubMed ID: 11891310
[TBL] [Abstract][Full Text] [Related]
14. In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie.
Thorne L; Terry LA
J Gen Virol; 2008 Dec; 89(Pt 12):3177-3184. PubMed ID: 19008409
[TBL] [Abstract][Full Text] [Related]
15. Different antigenicities of the N-terminal region of cellular and scrapie prion proteins.
Ushiki-Kaku Y; Iwamaru Y; Masujin K; Imamura M; Itohara S; Ogawa-Goto K; Hattori S; Yokoyama T
Microbiol Immunol; 2013 Nov; 57(11):792-6. PubMed ID: 24117858
[TBL] [Abstract][Full Text] [Related]
16. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
17. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
18. Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains.
Kuczius T; Groschup MH
Mol Med; 1999 Jun; 5(6):406-18. PubMed ID: 10415165
[TBL] [Abstract][Full Text] [Related]
19. Prion protein self-peptides modulate prion interactions and conversion.
Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
[TBL] [Abstract][Full Text] [Related]
20. Separation of scrapie prion infectivity from PrP amyloid polymers.
Wille H; Zhang GF; Baldwin MA; Cohen FE; Prusiner SB
J Mol Biol; 1996 Jun; 259(4):608-21. PubMed ID: 8683568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
